COVID-19: Cytokine Storm and Coagulopathy Markers Controlled With Nichi Glucan Variants; The First of Its Kind Report in a Clinical Study
Retrieved on:
Tuesday, October 12, 2021
Health, Infectious Diseases, Fitness & Nutrition, Clinical Trials, Research, Science, Biotechnology, COVID-19, Symbiosis, Brain, Trial of the century, Criterion, Nichi, Journal, Interleukin 6, CD8, Fungus, R, Multimedia, C-reactive protein, Safety, Immunomodulation, Microglia, Health, CD4, Immune system, Coagulopathy, LCR, Patient, NLR, Journal of the Neurological Sciences, Research, Immunity, Biomarker, Pharmaceutical industry, Vaccine
Cytokine storm and coagulopathy, the major life-threatening complications of COVID-19, whose biomarkers Interleukin-6 and D-Dimer were under control with consumption of two variants of Nichi Glucan food supplements from Japan in a pilot study.
Key Points:
- Cytokine storm and coagulopathy, the major life-threatening complications of COVID-19, whose biomarkers Interleukin-6 and D-Dimer were under control with consumption of two variants of Nichi Glucan food supplements from Japan in a pilot study.
- (Graphic: Business Wire)
The Covid-19 infection by SARS-COV-2 virus leads to several complications and those have succumbed to the illness developed cytokine storm because of an overreacting immune system, that should be tackled with immunomodulation. - Their combination has yielded this encouraging outcome and our interpretations are based on the present study as well as pre-clinical and clinical studies in healthy volunteers, he added ( https://doi.org/10.1101/2021.08.05.21261640 ).
- In the 1980s, evolution inspired, Prof Noboru Fujii started exploring this poly-extremo tolerant fungus, that was nature gifted.